Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
13.49
-0.02 (-0.15%)
Jun 27, 2025, 4:00 PM - Market closed
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $547.90 million as of June 27, 2025. Its market cap has decreased by -68.92% in one year.
Market Cap
547.90M
Enterprise Value
-154.23M
1-Year Change
-68.92%
Ranking
Category
Stock Price
$13.49
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $547.90M, an increase of 42.19%. That is a compound annual growth rate of 6.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 548.71M | -14.43% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |